As XOM prepares to release its Q1 2026 earnings on May 1, the timing aligns with volatile oil prices and escalating geopolitical tensions in the Middle East. In my view, the integrated oil major has capitalized on robust upstream performance and disciplined cost management, contributing to shares climbing nearly 30% year-to-date on the back of sustained energy demand. Refining margins have softened, however, and planned maintenance along with regional disruptions present headwinds. This report stands out for investors like me who are monitoring the company's path to record production targets in basins such as the Permian and Guyana, while assessing the strength of downstream operations. Broader dynamics—including OPEC+ decisions and global supply chains—further elevate its relevance for positioning in the energy sector.
Wall Street expects Q1 EPS of $1.01 on revenue of $85.29 billion, marking lower profitability compared to Q1 2025's $1.76 EPS and $83.13 billion in sales, according to 19 analysts. The Zacks Consensus is in line at $1.07 EPS.
From the company's April 8 outlook relative to Q4 2025, upstream earnings could increase by $1.1-$2.9 billion, driven by higher liquids prices ($1.9-$2.3B) and gas prices, though offset by Middle East volume impacts (-$0.5-$0.3B) and downtime. Energy Products anticipates a $4.2-$4.6 billion headwind from timing effects and maintenance (-$0.6-$0.4B). Chemical margins are projected to decline by $0.4-$0.2 billion. Overall, EPS should come in higher than Q4 excluding identified timing items, which are expected to reverse later in the year.
One thing that stands out are the key metrics: Permian output targeting over 20% growth, Guyana ramp-up, post-maintenance refining utilization, and free cash flow generation. XOM has a track record of frequently beating EPS estimates, though stock reactions have been mixed. I also checked peers using Tickeron’s AI Screener to contextualize these figures.
Sentiment heading into earnings feels balanced to me—optimism around upstream drivers tempered by caution on refining pressures and disruptions. XOM shares have benefited from crude price recovery, but history indicates post-earnings downside in 75% of the last 12 quarters. Implied volatility points to a potential 4-5% move. On the risk side, weaker volumes or downward guidance revisions could weigh on the stock; conversely, production beats might drive upside.
In my own research process, I frequently use Tickeron’s AI Screener, an AI-powered stock and ETF discovery tool that filters the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of stocks and ETFs with customizable criteria like industry, market cap, technical indicators, price patterns, and performance metrics, helping me pinpoint trade ideas, trending names, breakouts, and opportunities more efficiently than manual screening. If you're looking to streamline your stock analysis, it's a practical addition to the toolkit.
I'll be paying close attention to Q1 guidance on full-year 2026, particularly any reaffirmation of $27-29 billion in cash capex directed toward high-return projects. XOM aims for structural earnings growth via Permian expansion—targeting over 1 million barrels per day oil equivalent—and the Guyana Payara Phase 2 startup, which should add low-cost barrels.
Refining margins continue to face oversupply pressures, while chemicals depend on economic rebound. Upstream production reached records last year; Q2 maintenance effects and OPEC+ supply cues will be in focus. Shareholder returns persist through $4-5 billion in quarterly buybacks, backed by a solid balance sheet.
Longer term, I'm watching low-emission investments and carbon capture advancements amid energy transition shifts. Key catalysts ahead include Q2 results and initial Guyana cargoes.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where XOM advanced for three days, in of 369 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where XOM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for XOM just turned positive on May 13, 2026. Looking at past instances where XOM's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on May 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XOM as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
XOM moved below its 50-day moving average on April 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for XOM crossed bearishly below the 50-day moving average on April 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
XOM broke above its upper Bollinger Band on April 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for XOM entered a downward trend on April 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 43, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.489) is normal, around the industry mean (1.637). P/E Ratio (25.721) is within average values for comparable stocks, (18.590). Projected Growth (PEG Ratio) (1.411) is also within normal values, averaging (1.672). Dividend Yield (0.026) settles around the average of (0.060) among similar stocks. P/S Ratio (1.998) is also within normal values, averaging (1.306).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a distributer of crude oil, natural gas and petroleum products
Industry IntegratedOil